The expression and significance of Ezrin in human triple negative breast cancer
10.7652/jdyxb201604021
- VernacularTitle:Ezrin在三阴性乳腺癌中的表达及意义
- Author:
Hong ZHANG
;
Wen WANG
;
Tian TIAN
;
Xixi ZHAO
;
Xingcong MA
;
Wanjun YAN
;
Xiaoyan GAO
;
Shuqun ZHANG
- Publication Type:Journal Article
- Keywords:
Ezrin;
triple negative breast cancer;
immunohistochemistry
- From:
Journal of Xi'an Jiaotong University(Medical Sciences)
2016;37(4):574-577
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the expression and significance of Ezrin in triple negative breast cancer tissues .Methods We selected 102 cases ,including 24 ones of triple negative breast cancer ,58 ones of non‐triple negative breast cancer ,and 20 of benign breast disease .The expression of Ezrin in all the specimens was detected by SP immunohistochemistry .We observed whether there was any difference between the positive expression rates of Ezrin in the three groups . We also analyzed the correlation between Ezrin expression and clinicopathologic parameters of triple negative breast cancer .Results The positive expression rate of Ezrin in groups of triple negative breast cancer , non‐triple negative breast cancer , and benign breast disease was 15 .00% ,48 .28% and 75 .00% ,respectively . The difference between the three groups differed significantly ( P < 0 .01 ) . The high expression of Ezrin in triple negative breast cancer had relationship with histological grading and clinical TNM staging (P< 0 .05 ) , but not with patients' age , tumor size , or axillary lymph node metastasis ( P > 0 .05 ) . Conclusion Ezrin is highly expressed in triple negative breast cancer tissues ;therefore , it can be used as an important indicator of poor prognosis of triple negative breast cancer .
